Camila Moreira

Statistics

Publications

Citations

113

H-Index

Active since

2019

Affiliations

Universidade Estadual de Campinas (UNICAMP)(Current)

Camila Moreira is an author at Universidade Estadual de Campinas (UNICAMP) specializing in clinical pharmacology, diabetes pharmacotherapy, and sodium-glucose cotransporter 2 inhibitors.

ORCID

Publications per year

2019–2021

Publications

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial

Andrei C. Spósito, Íkaro Breder, Alexandre Soares et al. · Cardiovascular Diabetology · 2021 · 84 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial

Íkaro Breder, Jessica Cunha Breder, Isabella Bonilha et al. · Therapeutic Advances in Chronic Disease · 2020 · 15 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial

Riobaldo M.R. Cintra, Alexandre Soares, Íkaro Breder et al. · Diabetology & Metabolic Syndrome · 2019 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–3 of 3